Management of Systemic Lupus Erythematosus During Pregnancy.
Reproductive issues including contraception, fertility, and pregnancy are important components of the comprehensive care of women with systemic lupus erythematosus (SLE). SLE pregnancies are complicated due to risk for maternal disease exacerbation and potential for fetal and neonatal complications. Pre-pregnancy assessment is important to identify patients with severe disease-related damage who should avoid pregnancy, counsel patients to conceive when disease has been stable and inactive on appropriate medications, and assess relevant risk factors including renal disease, antiphospholipid antibody, and anti-Ro/SS-A and anti-La/SS-B antibodies. With careful planning, monitoring, and care, most women with SLE can anticipate a successful pregnancy.
Hospital for Special Surgery, Weill Cornell Medicine, New York, NY 10021; email: Sammaritanol@hss.edu.
Lisa R
LR
Sammaritano
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D017152:Antibodies, Antiphospholipid / Q000097:blood; D000962:Antimalarials / Q000009:adverse effects; D001942:Breast Feeding; D003267:Contraception; D003376:Counseling; D005260:Female; D005298:Fertility; D005938:Glucocorticoids / Q000009:adverse effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000150:complications* / Q000188:drug therapy*; D008181:Lupus Nephritis / Q000209:etiology; D000068097:Maternal Health; D016742:Preconception Care; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D011297:Prenatal Exposure Delayed Effects / Q000209:etiology; D027724:Reproductive Techniques, Assisted; D012307:Risk Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D017152:Antibodies, Antiphospholipid; D000962:Antimalarials; D005938:Glucocorticoids; D007166:Immunosuppressive Agents
antiphospholipid antibody; contraception; neonatal lupus erythematosus; preeclampsia